News

Published on 13 Nov 2024 on Investing.com

Axsome stock price target increased, rating held on strong sales By...


Article preview image

On Wednesday, RBC Capital Markets adjusted its outlook on shares of Axsome Therapeutics...

NASDAQ.AXSM price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Axsome Therapeutics, Inc. (AXSM): the Best Performing Healthcare Stock So Far in...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this...

Insider Monkey · via Yahoo Finance 20 Feb 2025

Axsome Q4 Loss Wider Than Expected, Auvelity Drives Sales Growth

Meanwhile, top-line data from the ENGAGE study and the SUSTAIN study, evaluating Sunosi for treat...

Zacks · via Yahoo Finance 19 Feb 2025

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

However, the growth potential is expected to have been partially offset by lower Kuvan sales. BMR...

Zacks · via Yahoo Finance 17 Feb 2025

Axsome therapeutics CFO sells $1.95 million in stock By Investing.com

Axsome therapeutics CFO sells $1.95 million in stock

Investing.com 15 Feb 2025

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Profit Outlook

Axsome Therapeutics, Inc. (NASDAQ:AXSM) is possibly approaching a major achievement in its busine...

Simply Wall St. · via Yahoo Finance 6 Jan 2025

Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed...

On Monday, Axsome Therapeutics, Inc. (NASDAQ:AXSM) released data from ACCORD-2, ADVANCE-2, and...

Benzinga · via Yahoo Finance 31 Dec 2024

Tesla, Avago among Monday’s market cap stock movers By Investing.com

Tesla, Avago among Monday’s market cap stock movers

Investing.com 30 Dec 2024

Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In...

On Tuesday, Axsome Therapeutics Inc (NASDAQ:AXSM) said AXS-12 statistically significantly reduced...

Benzinga · via Yahoo Finance 27 Nov 2024

Axsome stock price target increased, rating held on strong sales By...

On Wednesday, RBC Capital Markets adjusted its outlook on shares of Axsome Therapeutics...

Investing.com 13 Nov 2024

Earnings call: Axsome Therapeutics reports record quarterly revenue By...

The company's treatment for major depressive disorder, Auvelity, was a significant contributor wi...

Investing.com 12 Nov 2024